Catalyst Wire Dossier Catalyst Wire Dossier

ZEMDRI

plazomicin · Cipla Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ZEMDRI, covering 2018-06-25 to 2023-02-10. Get the full timeline:

Most recent: FDA Approved: ZEMDRI (PLAZOMICIN) — Supplemental Application (Cipla Therapeutics Inc.)

See pricing